Covered recipient · General Payments record
SHARON NANCY FARBER
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$17,451.37
- Reported across 1,023 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $579.90 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $175.61 | 18 |
| MDD US Operations, LLC | $64.42 | 3 |
| CSL Behring | $62.77 | 2 |
| Biogen, Inc. | $51.19 | 2 |
| TG THERAPEUTICS, INC. | $38.88 | 2 |
| Amgen Inc. | $38.22 | 2 |
| ARGENX US, INC. | $27.17 | 1 |
| Neurelis, Inc. | $26.96 | 1 |
| SK Life Science, Inc. | $25.51 | 1 |
| Neurocrine BioSciences, Inc. | $18.45 | 1 |
| Alexion Pharmaceuticals, Inc. | $18.36 | 1 |
| Acorda Therapeutics, Inc | $17.67 | 1 |
| Lilly USA, LLC | $14.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.74 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103709879 | CMS |
| ABBVIE INC. | $1.39 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103709881 | CMS |
| ABBVIE INC. | $1.38 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103709883 | CMS |
| ABBVIE INC. | $14.04 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103709885 | CMS |
| ABBVIE INC. | $5.30 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103709887 | CMS |
| ABBVIE INC. | $0.90 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103709889 | CMS |
| ABBVIE INC. | $2.39 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103709891 | CMS |
| ABBVIE INC. | $0.78 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103709893 | CMS |
| ABBVIE INC. | $13.85 | 03/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103709895 | CMS |
| ABBVIE INC. | $16.38 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103709897 | CMS |
| ABBVIE INC. | $8.42 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103709899 | CMS |
| ABBVIE INC. | $12.09 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103709901 | CMS |
| ABBVIE INC. | $15.58 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103709903 | CMS |
| ABBVIE INC. | $16.19 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103709905 | CMS |
| ABBVIE INC. | $17.16 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103709907 | CMS |
| ABBVIE INC. | $5.02 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103709909 | CMS |
| ABBVIE INC. | $17.72 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103709911 | CMS |
| ABBVIE INC. | $21.28 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103709913 | CMS |
| Acorda Therapeutics, Inc | $17.67 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142349998 | CMS |
| Alexion Pharmaceuticals, Inc. | $18.36 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093999163 | CMS |
| Amgen Inc. | $18.36 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115614148 | CMS |
| Amgen Inc. | $19.86 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115614156 | CMS |
| ARGENX US, INC. | $27.17 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142127752 | CMS |
| Biogen, Inc. | $27.87 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104852258 | CMS |
| Biogen, Inc. | $23.32 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104847672 | CMS |
| CSL Behring | $23.27 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134654425 | CMS |
| CSL Behring | $39.50 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134654573 | CMS |
| Lilly USA, LLC | $14.69 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135426060 | CMS |
| MDD US Operations, LLC | $22.45 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147764951 | CMS |
| MDD US Operations, LLC | $19.87 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147764555 | CMS |
| MDD US Operations, LLC | $22.10 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147764949 | CMS |
| Neurelis, Inc. | $26.96 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145641135 | CMS |
| Neurocrine Biosciences, Inc. | $18.45 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150864065 | CMS |
| SK Life Science, Inc. | $25.51 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154150660 | CMS |
| TG Therapeutics, Inc. | $16.68 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136884436 | CMS |
| TG Therapeutics, Inc. | $22.20 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136884300 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.